Skip Navigation

European Heart Journal 2000 21(11):868-871; doi:10.1053/euhj.1999.2050
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Rosano, G.M.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosano, G.M.C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Androgens and coronary artery disease. A sex-specific effect of sex hormones?

G.M.C. Rosano

San Raffaele—EUR, Rome, Italy

References

  1. Stigler LH, Tulgan J. Treatment of angina pectoris by testosterone propionate. NY State J Med. 1943;43:1424–1428
  2. Hamm L. Testosterone propionate in the treatment of angina pectoris. J Clin Endocrinol. 1942;2:325–328
  3. Meriggiola MC, Marcovina S, Paulsen CA, Bremner WJ. Testosterone enanthate at a dose of 200 mg/week decreases HDL-cholesterol levels in healthy men. Int J Androl. 1995;18:237–242[ISI][Medline]
  4. Haffner SM, Ksuhwaha RS, Foster DM, Applebaum-Bowden D, Hazzard WR. Studies on the metabolic mechanism of reduced high density lipoprotein during anabolic steroid therapy. Metabolism. 1983;32:413–417[CrossRef][ISI][Medline]
  5. Enzi GB, Giada F, Zuliani G. Lipid and apoprotein modifications in body builders during and after self administration of anabolic steroids. Metabolism. 1990;39:203–208[CrossRef][ISI][Medline]
  6. Kantor ME, Bianchini A, Bernier D, Sady SP, Thompson PD. Androgens reduce HDL-2 cholesterol and increse hepatic triglyceride lipase activity. Med Sci Sports Exercise. 1985;17:462–465[CrossRef][ISI][Medline]
  7. Asscherman H, Gooren LJG, Megens JAJ, Nauta J, Kloosterboer HJ, Eikelboom F. Serum testosterone is the major determinant of male-female differences in serum levels of high-density lipoprotein-cholesterol and HDL-2 cholesterol. Metabolism. 1994;43:935–939[CrossRef][ISI][Medline]
  8. Lovejoy JC, Bray GA, Bourgeois MO. Exogenous androgens influence body composition and regional body fat distribution in obese post-menopausal women. J Clin Endocrinol Metab. 1996;81:2198–2203[Abstract]
  9. Alexandersen, P, Haarbo, J, Byrialsen, I, Lawaetz, H, Christiansen, C, Natural androgens inhibit male atherosclerosis, A study in castrated, cholesterol fed rabbits, Circ Res, 1999, 84, 813, 9
  10. Adams MR, Williams JK, Kaplan JR. Effects of androgens on coronary atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arterioscler Thromb Vasc Biol. 1995;15:562–570[Abstract/Free Full Text]
  11. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab. 1992;75:1092–1098[Abstract]
  12. Morley ME, Perry MM, Kaiser FE, Kraenzle D, Jensen E, Houston K, Mattammal M, Perry HMJr. Effects of testosterone replacement in old hypogonadal males: a preliminary study. J Am Geriatr Soc. 1993;41:149–152[ISI][Medline]
  13. Ellyin FM. The long term beneficial effect of low dose testosterone in the aging male. Proc Endocr Soc. 1995;2:127
  14. Phillips GB. Relationship between serum sex hormones and glucose, insulin, and lipid abnormalities in men with myocardial infarction. Proc Natl Acad Sci. 1977;74:1729–1733[Abstract/Free Full Text]
  15. Hamalainen E, Adlercreutz H, Ehnholm C, Puska P. Relationships of serum lipoproteins and apoproteins to sex hormones and to the binding capacity of sex hormone binding globulin in healthy Finnish men. Metabolism. 1986;35:535–541[CrossRef][ISI][Medline]
  16. Haffner SM, Mykkänen L, Valdez RA, Katz MS. Relationship of sex hormones to lipids and lipoproteins in non-diabetic men. J Clin Endocrinol Metab. 1993;77:1610–1615[Abstract]
  17. Freedman DS, O'Brien TR, Flanders WD, DeStefano F, Barboriak JJ. Relation of sex testosterone levels to high density lipoprotein cholesterol and other characteristics in men. Arterioscler Thromb. 1991;11:307–315[Abstract/Free Full Text]
  18. Barrett-Connor E. Testosterone and risk factors for cardiovascular disease in men. Diabete Metab. 1995;21:156–161[ISI][Medline]
  19. Barrett-Connor E, Kaw KS. Endogenous sex hormone levels and cardiovascular disease in men. A prospective population based study. Circulation. 1988;78:539–543[Abstract/Free Full Text]
  20. Zmuda JM, Cauley JA, Kriska A, Glynn NW, Gutai JP, Kuller LH. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13 year follow up of former Multiple Risk Factor Intervantion Trial participants. Am J Epidemiol. 1997;146:609–617[Abstract/Free Full Text]
  21. Barrett-Connor E, Khaw T, Yenn SCC. A prospective study of dehydroepiandrosterone sulphate, mortality and cardiovascular disease. N Engl J Med. 1986;315:1519–1524[Abstract]
  22. Hautanen A, Manttari V, Manninin V. Adrenal androgens and testosterone as coronary risk factors in the Helsinki heart study. Atherosclerosis. 1994;105:191–200[CrossRef][ISI][Medline]
  23. Phillips GB, Pinkernell BH, Jing TY. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb. 1994;14:701–706[Abstract/Free Full Text]
  24. Hauner H, Stangl K, Burger K, Busch U, Blomer H, Pfeiffer EF. Sex hormone concentrations in men with angiographically assessed coronary artery disease—relationship to obesity and body fat distribution. Klin Wochenschr. 1991;69:664–668[CrossRef][ISI][Medline]
  25. Sewdarsen M, Vythilingum S, Jialal I, Desai RK. Abnormalities in sex hormones are a risk factor for premature manifestation of coronary artery disease in South African Indian men. Atherosclerosis. 1990;83:111–117[CrossRef][ISI][Medline]
  26. Aksut SV, Aksut G, Karamehmetoglu A, Oram E. The determination of serum estradiol, testosterone and progesterone in acute myocardial infarction. Jpn Heart J. 1986;27:825–837[Medline]
  27. Barrett-Connor E, Goodman-Gruen D. The epidemiology of DHEAS and cardiovascular disease. Ann NY Acad Sci. 1995;774:259–270[Abstract]
  28. Haffner SM, Moss SE, Klein BE, Klein R. Sex hormones and DHEASO4 in relation to ischemic heart disease in diabetic subjects: a WEDSR study of diabetic retinopathy. Diabetes Care. 1996;19:1045–1050[Abstract]
  29. Jeppesen LL, Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS, Winther K. Decreased serum testosterone in men with acute ischemic stroke. Arterioscler Thromb Vasc Biol. 1996;16:749–754[Abstract/Free Full Text]
  30. Phillips GB, Castelli WP, Abbott RD, McNamara PM. Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort. Am J Med. 1983;74:863–869[CrossRef][ISI][Medline]
  31. Zhao SP, Li XP. The association of low plasma testosterone level with coronary artery disease in Chinese men. Int J Cardiol. 1998;63:161–164[CrossRef][ISI][Medline]
  32. Cauley SA, Gutai JP, Kuller LH, Dai S. Usefulness of sex steroid hormone levels in predicting coronary artery disease in men. Am J Cardiol. 1987;60:771–777[CrossRef][ISI][Medline]
  33. Mendoza SG, Zerpa A, Carrasco H. Estradiol, testosterone, apoplipoproteins, opolipoprotein-cholesterol and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion. Artery. 1983;2:1–23
  34. English KM, Mandour O, Steeds RP, Diver MJ, Jones TH, Channer KS. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J. 2000;21:890–894[Abstract/Free Full Text]
  35. Phillips GB, Pinkernell BH, Jing TY. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 1994;14:701–706[Abstract/Free Full Text]
  36. Rosano GMC, De Ziegler D, Pagnotta P. Plasma testosterone levels in male patients with coronary artery disease. Eur Heart J. 1998;19:141A
  37. Webb CM, McNeill JG, Hayward CS, de Zeigler D, Collins P. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation. 1999;100:1690–1696[Abstract/Free Full Text]
  38. Rosano GM, Leonardo F, Pagnotta P. Acute anti-ischemic effect ofz testosterone in men with coronary artery disease. Circulation. 1999;99:1666–1670[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CirculationHome page
M. Muller, A. W. van den Beld, M. L. Bots, D. E. Grobbee, S. W.J. Lamberts, and Y. T. van der Schouw
Endogenous Sex Hormones and Progression of Carotid Atherosclerosis in Elderly Men
Circulation, May 4, 2004; 109(17): 2074 - 2079.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Rosano, G.M.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosano, G.M.C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?